"In a response to mounting evidence, the US Food and Drug Administration (FDA) announced that the diabetes drug metformin can be used safely in patients with mild and, in some cases, moderate kidney impairment after decades of warning against it. "...
Methylene Blue (methylene blue injection) should not be given by subcutaneous or intrathecal injection.
Methylene Blue (methylene blue injection) must be injected intravenously very slowly over a period of several minutes to prevent local high concentration of the compound from producing additional methemoglobin. Do not exceed recommended dosage.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 7/22/2008
Additional Methylene Blue Information
Report Problems to the Food and Drug Administration
Find out what women really need.